Trial Profile
Clinical Trials Insight: 700032903
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 23 Apr 2008
Price :
$35
*
At a glance
- Drugs Golnerminogene pradenovec (Primary) ; Antineoplastics
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors GenVec
- 23 Apr 2008 New trial record.